Atlas Trials

Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

Clinical trial NCT01182142 · COMPLETED

Trial details

NCT number
NCT01182142
Sponsor
Kidney Cancer Research Bureau
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2007-09-01
Primary completion
2009-09-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.